|
| 36793435 | Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor. | ACS Med Chem Lett | 2023 |
| 37660910 | G protein-receptor kinases 5/6 are the key regulators of GÂ protein-coupled receptor 35-arrestin interactions. | J Biol Chem | 2023 |
| 36948210 | Discovery of Nanomolar DCAF1 Small Molecule Ligands. | J Med Chem | 2023 |
| 37075613 | Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels. | Biomaterials | 2023 |
| 34958585 | Correction to "Structure-Activity Relationship of USP5 Inhibitors". | J Med Chem | 2022 |
| 35783295 | CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding. | Nat Rev Chem | 2022 |
| 36030052 | G protein-coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulin. | J Biol Chem | 2022 |
| 34963044 | Correction to "Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma". | J Med Chem | 2022 |
| 33476303 | A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity. | JCI Insight | 2021 |
| 33522809 | Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2. | J Med Chem | 2021 |
| 33591753 | A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6. | J Med Chem | 2021 |
| 34648286 | Structure-Activity Relationship of USP5 Inhibitors. | J Med Chem | 2021 |
| 34589290 | The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia. | Oncoimmunology | 2021 |
| 34662547 | Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells. | J Mol Biol | 2021 |
| 34301934 | Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival. | Nat Commun | 2021 |
| 34291633 | Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma. | J Med Chem | 2021 |
| 32369358 | Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. | J Med Chem | 2020 |
| 32094923 | A drug discovery platform to identify compounds that inhibit EGFR triple mutants. | Nat Chem Biol | 2020 |
| 32758183 | Antagonists of the serotonin receptor 5A target human breast tumor initiating cells. | BMC Cancer | 2020 |
| 32778845 | Functional characterization of a PROTAC directed against BRAF mutant V600E. | Nat Chem Biol | 2020 |
| 32409666 | Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response. | Nat Commun | 2020 |
| 32457299 | Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response. | Nat Commun | 2020 |
| 30696771 | Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport. | J Biol Chem | 2019 |
| 30840432 | Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic Consequence. | ACS Chem Biol | 2019 |
| 31173706 | The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids. | Cell Stem Cell | 2019 |
| 30359161 | Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9. | SLAS Discov | 2019 |
| 30300580 | MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis. | Cancer Cell | 2018 |
| 30288907 | Discovery of an MLLT1/3 YEATS Domain Chemical Probe. | Angew Chem Int Ed Engl | 2018 |
| 28273451 | Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer. | Cell Rep | 2017 |
| 28161682 | Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model. | Biomaterials | 2017 |
| 27076069 | Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy. | Cell Metab | 2016 |
| 27618721 | Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay. | Stem Cell Reports | 2016 |
| 27587383 | Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells. | Haematologica | 2016 |
| 27449082 | Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells. | Oncotarget | 2016 |
| 26916338 | Small molecules reveal an alternative mechanism of Bax activation. | Biochem J | 2016 |
| 26958703 | Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). | J Med Chem | 2016 |
| 26952093 | PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. | J Transl Med | 2016 |
| 25832785 | Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cells. | Apoptosis | 2015 |
| 26331536 | Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. | Nature | 2015 |
| 26379026 | Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | Nat Chem Biol | 2015 |
| 26471359 | WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma. | Cancer Res | 2015 |
| 26158521 | FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing. | Cell Death Dis | 2015 |
| 26167872 | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | Nat Chem Biol | 2015 |
| 26058080 | Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia. | Cancer Cell | 2015 |
| 24487029 | shRNA kinome screen identifies TBK1 as a therapeutic target for HER2+ breast cancer. | Cancer Res | 2014 |
| 25330770 | Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K. | EMBO Mol Med | 2014 |
| 25164867 | Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors. | Nat Commun | 2014 |
| 25136132 | (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. | Proc Natl Acad Sci U S A | 2014 |
| 22989411 | Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5. | Biochem J | 2013 |
| 24900672 | Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction. | ACS Med Chem Lett | 2013 |